Neuromodulation Devices and Implantable Infusion Pumps
Market
Neuromodulation Devices and Implantable Infusion
Pumps Market Scope: Industry Analysis, Market
Size, Growth, Trends Till 2031
Request Sample Report
Neuromodulation Devices and Implantable Infusion Pumps Market Size and Growth
The global Neuromodulation Devices and Implantable Infusion Pumps market is expected to experience steady growth due to increasing prevalence of chronic pain and neurological disorders. Market size is estimated to reach $10 billion by 2025, driven by technological advancements and rising demand for minimally invasive therapies.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Medtronic
◍ Boston Scientific Corporation
◍ St. Jude Medical
◍ Synapse Biomedical
◍ Nevro Corporation
◍ Neuropace
◍ Cyberonics
◍ Autonomic Technologies
◍ Avery Biomedical
◍ Greatbatch Medical
The competitive landscape of the Neuromodulation Devices and Implantable Infusion Pumps Market is dominated by companies such as Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, and Greatbatch Medical. These companies offer a wide range of products that help in treating chronic pain, neurological disorders, and other conditions through neuromodulation techniques.
Medtronic, a leader in the market, generated $30.6 billion in sales revenue in 2020. Boston Scientific Corporation reported $9.9 billion in sales revenue in 2020, while St. Jude Medical earned $5.8 billion.
Request Sample Report
Market Segmentation
By Application
◍ Epilepsy
◍ Pain
By Product
◍ Other ◍ Parkinson's Disease
◍ Spinal Cord Stimulation
◍ Deep Brain Stimulation
◍ Sacral Nerve Stimulation
◍ Other Request Sample Report
◍ Vagal Nerve Stimulation
◍ Gastric Stimulation
◍ Transcranial Magnetic Stimulation
◍ Transcutaneous Electrical Stimulation
Market Growth
Request Sample Report
$ X Billion USD
